Venture capital for companies developing innovative therapeutics

Our Team

We are driven by the quest for new and better medicines.

Innovative Drug Development

Be invested in an attractive growth market.

BB Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats.

BB Pureos Bioventures strives to impact patients’ lives by advancing innovative treatments for severe diseases.

We are driven by the quest for new and better medicines

Our Portfolio

Our companies develop innovative medicines.

Latest News

We are happy to share our latest progress.

May 2021

Hummingbird Bioscience Raises US$125 Million in Series C Financing

April 2021

ImCheck Announces Initiation of U.S. Enrollment in Phase I/IIa EVICTION Trial for ICT01

April 2021

Pureos Bioventures expands fund size to USD 205 million

Member of